Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

ESTA vs DBVT vs ALGN vs ALKS vs PRGO

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
ESTA
Establishment Labs Holdings Inc.

Medical - Devices

HealthcareNASDAQ • CR
Market Cap$2.12B
5Y Perf.+264.7%
DBVT
DBV Technologies S.A.

Biotechnology

HealthcareNASDAQ • FR
Market Cap$1712.35T
5Y Perf.-59.3%
ALGN
Align Technology, Inc.

Medical - Devices

HealthcareNASDAQ • US
Market Cap$12.06B
5Y Perf.-31.3%
ALKS
Alkermes plc

Biotechnology

HealthcareNASDAQ • IE
Market Cap$5.90B
5Y Perf.+113.9%
PRGO
Perrigo Company plc

Drug Manufacturers - Specialty & Generic

HealthcareNYSE • IE
Market Cap$1.61B
5Y Perf.-78.6%

ESTA vs DBVT vs ALGN vs ALKS vs PRGO — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
ESTA logoESTA
DBVT logoDBVT
ALGN logoALGN
ALKS logoALKS
PRGO logoPRGO
IndustryMedical - DevicesBiotechnologyMedical - DevicesBiotechnologyDrug Manufacturers - Specialty & Generic
Market Cap$2.12B$1712.35T$12.06B$5.90B$1.61B
Revenue (TTM)$211M$0.00$4.10B$1.56B$4.18B
Net Income (TTM)$-51M$-168M$430M$153M$-1.82B
Gross Margin69.3%67.7%65.4%34.2%
Operating Margin-18.5%14.4%12.3%-4.1%
Forward P/E14.9x24.8x5.5x
Total Debt$264M$22M$114M$70M$3.97B
Cash & Equiv.$76M$194M$1.08B$1.12B$532M

ESTA vs DBVT vs ALGN vs ALKS vs PRGOLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

ESTA
DBVT
ALGN
ALKS
PRGO
StockMay 20May 26Return
Establishment Labs … (ESTA)100364.7+264.7%
DBV Technologies S.… (DBVT)10040.7-59.3%
Align Technology, I… (ALGN)10068.7-31.3%
Alkermes plc (ALKS)100213.9+113.9%
Perrigo Company plc (PRGO)10021.4-78.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: ESTA vs DBVT vs ALGN vs ALKS vs PRGO

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: ESTA and ALGN are tied at the top with 2 categories each (5-stock set) — the right choice depends on your priorities. Align Technology, Inc. is the stronger pick specifically for profitability and margin quality and operational efficiency and capital deployment. PRGO and ALKS also each lead in at least one category. As sector peers, any of these can serve as alternatives in the same allocation.
ESTA
Establishment Labs Holdings Inc.
The Growth Play

ESTA has the current edge in this matchup, primarily because of its strength in growth exposure and long-term compounding.

  • Rev growth 27.1%, EPS growth 42.7%, 3Y rev CAGR 9.3%
  • 191.0% 10Y total return vs ALKS's -11.0%
  • 27.1% revenue growth vs DBVT's -100.0%
  • +116.5% vs PRGO's -51.2%
Best for: growth exposure and long-term compounding
DBVT
DBV Technologies S.A.
The Healthcare Pick

Among these 5 stocks, DBVT doesn't own a clear edge in any measured category.

Best for: healthcare exposure
ALGN
Align Technology, Inc.
The Quality Compounder

ALGN is the #2 pick in this set and the best alternative if quality and efficiency is your priority.

  • 10.5% margin vs PRGO's -43.5%
  • 6.9% ROA vs DBVT's -89.0%
Best for: quality and efficiency
ALKS
Alkermes plc
The Defensive Pick

ALKS is the clearest fit if your priority is sleep-well-at-night and defensive.

  • Lower volatility, beta 1.06, Low D/E 3.8%, current ratio 3.55x
  • Beta 1.06, current ratio 3.55x
  • Beta 1.06 vs ALGN's 1.66
Best for: sleep-well-at-night and defensive
PRGO
Perrigo Company plc
The Income Pick

PRGO ranks third and is worth considering specifically for income & stability.

  • Dividend streak 10 yrs, beta 1.18, yield 9.8%
  • Lower P/E (5.5x vs 24.8x)
  • 9.8% yield; 10-year raise streak; the other 4 pay no meaningful dividend
Best for: income & stability
See the full category breakdown
CategoryWinnerWhy
GrowthESTA logoESTA27.1% revenue growth vs DBVT's -100.0%
ValuePRGO logoPRGOLower P/E (5.5x vs 24.8x)
Quality / MarginsALGN logoALGN10.5% margin vs PRGO's -43.5%
Stability / SafetyALKS logoALKSBeta 1.06 vs ALGN's 1.66
DividendsPRGO logoPRGO9.8% yield; 10-year raise streak; the other 4 pay no meaningful dividend
Momentum (1Y)ESTA logoESTA+116.5% vs PRGO's -51.2%
Efficiency (ROA)ALGN logoALGN6.9% ROA vs DBVT's -89.0%

ESTA vs DBVT vs ALGN vs ALKS vs PRGO — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

ESTAEstablishment Labs Holdings Inc.

Segment breakdown not available.

DBVTDBV Technologies S.A.

Segment breakdown not available.

ALGNAlign Technology, Inc.
FY 2025
Clear Aligner
80.4%$3.2B
Scanners And Services
19.6%$790M
ALKSAlkermes plc
FY 2025
Vivitrol
39.8%$468M
Aristada And Aristada Initio
31.5%$370M
Manufactured Product And Royalty
24.8%$291M
Manufacturing Revenue
3.9%$46M
PRGOPerrigo Company plc
FY 2025
Consumer Self-Care Americas
60.8%$2.6B
Consumer Self-Care International
39.2%$1.7B

ESTA vs DBVT vs ALGN vs ALKS vs PRGO — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLPRGOLAGGINGDBVT

Income & Cash Flow (Last 12 Months)

ESTA leads this category, winning 3 of 6 comparable metrics.

PRGO and DBVT operate at a comparable scale, with $4.2B and $0 in trailing revenue. ALGN is the more profitable business, keeping 10.5% of every revenue dollar as net income compared to PRGO's -43.5%. On growth, ESTA holds the edge at +45.2% YoY revenue growth, suggesting stronger near-term business momentum.

MetricESTA logoESTAEstablishment Lab…DBVT logoDBVTDBV Technologies …ALGN logoALGNAlign Technology,…ALKS logoALKSAlkermes plcPRGO logoPRGOPerrigo Company p…
RevenueTrailing 12 months$211M$0$4.1B$1.6B$4.2B
EBITDAEarnings before interest/tax-$32M-$112M$790M$212M$58M
Net IncomeAfter-tax profit-$51M-$168M$430M$153M-$1.8B
Free Cash FlowCash after capex-$57M-$151M$717M$392M$108M
Gross MarginGross profit ÷ Revenue+69.3%+67.7%+65.4%+34.2%
Operating MarginEBIT ÷ Revenue-18.5%+14.4%+12.3%-4.1%
Net MarginNet income ÷ Revenue-24.2%+10.5%+9.8%-43.5%
FCF MarginFCF ÷ Revenue-27.2%+17.5%+25.1%+2.6%
Rev. Growth (YoY)Latest quarter vs prior year+45.2%+6.2%+28.2%-7.2%
EPS Growth (YoY)Latest quarter vs prior year+92.6%+91.5%+23.6%-4.1%-56.4%
ESTA leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

PRGO leads this category, winning 5 of 6 comparable metrics.

At 24.8x trailing earnings, ALKS trades at a 17% valuation discount to ALGN's 29.8x P/E. On an enterprise value basis, PRGO's 7.4x EV/EBITDA is more attractive than ALKS's 17.3x.

MetricESTA logoESTAEstablishment Lab…DBVT logoDBVTDBV Technologies …ALGN logoALGNAlign Technology,…ALKS logoALKSAlkermes plcPRGO logoPRGOPerrigo Company p…
Market CapShares × price$2.1B$1712.35T$12.1B$5.9B$1.6B
Enterprise ValueMkt cap + debt − cash$2.3B$1712.35T$11.1B$4.9B$5.1B
Trailing P/EPrice ÷ TTM EPS-41.88x-0.76x29.80x24.76x-1.14x
Forward P/EPrice ÷ next-FY EPS est.14.85x5.53x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple13.92x17.25x7.42x
Price / SalesMarket cap ÷ Revenue10.03x2.99x4.00x0.38x
Price / BookPrice ÷ Book value/share90.61x0.66x3.02x3.28x0.55x
Price / FCFMarket cap ÷ FCF24.57x12.28x11.12x
PRGO leads this category, winning 5 of 6 comparable metrics.

Profitability & Efficiency

ALGN leads this category, winning 6 of 9 comparable metrics.

ALGN delivers a 10.7% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $-2 for ESTA. ALGN carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to ESTA's 11.23x. On the Piotroski fundamental quality scale (0–9), ALGN scores 7/9 vs PRGO's 4/9, reflecting strong financial health.

MetricESTA logoESTAEstablishment Lab…DBVT logoDBVTDBV Technologies …ALGN logoALGNAlign Technology,…ALKS logoALKSAlkermes plcPRGO logoPRGOPerrigo Company p…
ROE (TTM)Return on equity-2.0%-130.2%+10.7%+8.8%-50.7%
ROA (TTM)Return on assets-15.0%-89.0%+6.9%+5.4%-19.8%
ROICReturn on invested capital-14.6%+15.4%+18.9%+3.7%
ROCEReturn on capital employed-14.1%-145.7%+14.5%+14.2%+4.3%
Piotroski ScoreFundamental quality 0–944774
Debt / EquityFinancial leverage11.23x0.13x0.03x0.04x1.35x
Net DebtTotal debt minus cash$189M-$172M-$965M-$1.0B$3.4B
Cash & Equiv.Liquid assets$76M$194M$1.1B$1.1B$532M
Total DebtShort + long-term debt$264M$22M$114M$70M$4.0B
Interest CoverageEBIT ÷ Interest expense-1.30x-189.82x389.13x32.30x-7.20x
ALGN leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

Evenly matched — ESTA and DBVT and ALKS each lead in 2 of 6 comparable metrics.

A $10,000 investment in ALKS five years ago would be worth $16,091 today (with dividends reinvested), compared to $2,814 for ALGN. Over the past 12 months, ESTA leads with a +116.5% total return vs PRGO's -51.2%. The 3-year compound annual growth rate (CAGR) favors DBVT at 6.2% vs PRGO's -25.2% — a key indicator of consistent wealth creation.

MetricESTA logoESTAEstablishment Lab…DBVT logoDBVTDBV Technologies …ALGN logoALGNAlign Technology,…ALKS logoALKSAlkermes plcPRGO logoPRGOPerrigo Company p…
YTD ReturnYear-to-date+4.6%+4.9%+7.9%+25.3%-13.5%
1-Year ReturnPast 12 months+116.5%+110.4%-2.2%+16.5%-51.2%
3-Year ReturnCumulative with dividends+6.4%+19.7%-45.0%+14.5%-58.1%
5-Year ReturnCumulative with dividends+0.6%-69.1%-71.9%+60.9%-60.1%
10-Year ReturnCumulative with dividends+191.0%-87.0%+122.8%-11.0%-77.7%
CAGR (3Y)Annualised 3-year return+2.1%+6.2%-18.1%+4.6%-25.2%
Evenly matched — ESTA and DBVT and ALKS each lead in 2 of 6 comparable metrics.

Risk & Volatility

ALKS leads this category, winning 2 of 2 comparable metrics.

ALKS is the less volatile stock with a 1.06 beta — it tends to amplify market swings less than ALGN's 1.66 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ALKS currently trades 96.7% from its 52-week high vs PRGO's 41.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricESTA logoESTAEstablishment Lab…DBVT logoDBVTDBV Technologies …ALGN logoALGNAlign Technology,…ALKS logoALKSAlkermes plcPRGO logoPRGOPerrigo Company p…
Beta (5Y)Sensitivity to S&P 5001.27x1.26x1.65x1.00x1.21x
52-Week HighHighest price in past year$83.31$26.18$208.31$36.60$28.44
52-Week LowLowest price in past year$32.75$7.53$122.00$25.17$9.23
% of 52W HighCurrent price vs 52-week peak+86.5%+76.3%+80.8%+96.7%+41.2%
RSI (14)Momentum oscillator 0–10066.848.144.660.260.9
Avg Volume (50D)Average daily shares traded455K252K1.1M2.3M3.4M
ALKS leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

PRGO leads this category, winning 1 of 1 comparable metric.

Analyst consensus: ESTA as "Buy", DBVT as "Buy", ALGN as "Buy", ALKS as "Buy", PRGO as "Hold". Consensus price targets imply 208.9% upside for PRGO (target: $36) vs 18.0% for ESTA (target: $85). PRGO is the only dividend payer here at 9.81% yield — a key consideration for income-focused portfolios.

MetricESTA logoESTAEstablishment Lab…DBVT logoDBVTDBV Technologies …ALGN logoALGNAlign Technology,…ALKS logoALKSAlkermes plcPRGO logoPRGOPerrigo Company p…
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuyHold
Price TargetConsensus 12-month target$85.00$46.33$203.60$46.00$36.20
# AnalystsCovering analysts1415332836
Dividend YieldAnnual dividend ÷ price+9.8%
Dividend StreakConsecutive years of raises0010
Dividend / ShareAnnual DPS$1.15
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%+3.9%+0.5%0.0%
PRGO leads this category, winning 1 of 1 comparable metric.
Key Takeaway

PRGO leads in 2 of 6 categories (Valuation Metrics, Analyst Outlook). ESTA leads in 1 (Income & Cash Flow). 1 tied.

Best OverallPerrigo Company plc (PRGO)Leads 2 of 6 categories
Loading custom metrics...

ESTA vs DBVT vs ALGN vs ALKS vs PRGO: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is ESTA or DBVT or ALGN or ALKS or PRGO a better buy right now?

For growth investors, Establishment Labs Holdings Inc.

(ESTA) is the stronger pick with 27. 1% revenue growth year-over-year, versus -5. 2% for Alkermes plc (ALKS). Alkermes plc (ALKS) offers the better valuation at 24. 8x trailing P/E, making it the more compelling value choice. Analysts rate Establishment Labs Holdings Inc. (ESTA) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — ESTA or DBVT or ALGN or ALKS or PRGO?

On trailing P/E, Alkermes plc (ALKS) is the cheapest at 24.

8x versus Align Technology, Inc. at 29. 8x. On forward P/E, Perrigo Company plc is actually cheaper at 5. 5x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — ESTA or DBVT or ALGN or ALKS or PRGO?

Over the past 5 years, Alkermes plc (ALKS) delivered a total return of +60.

9%, compared to -71. 9% for Align Technology, Inc. (ALGN). Over 10 years, the gap is even starker: ESTA returned +190. 0% versus DBVT's -87. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — ESTA or DBVT or ALGN or ALKS or PRGO?

By beta (market sensitivity over 5 years), Alkermes plc (ALKS) is the lower-risk stock at 1.

00β versus Align Technology, Inc. 's 1. 65β — meaning ALGN is approximately 66% more volatile than ALKS relative to the S&P 500. On balance sheet safety, Align Technology, Inc. (ALGN) carries a lower debt/equity ratio of 3% versus 11% for Establishment Labs Holdings Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — ESTA or DBVT or ALGN or ALKS or PRGO?

By revenue growth (latest reported year), Establishment Labs Holdings Inc.

(ESTA) is pulling ahead at 27. 1% versus -5. 2% for Alkermes plc (ALKS). On earnings-per-share growth, the picture is similar: Establishment Labs Holdings Inc. grew EPS 42. 7% year-over-year, compared to -723. 2% for Perrigo Company plc. Over a 3-year CAGR, ALKS leads at 9. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — ESTA or DBVT or ALGN or ALKS or PRGO?

Alkermes plc (ALKS) is the more profitable company, earning 16.

4% net margin versus -33. 5% for Perrigo Company plc — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALKS leads at 17. 2% versus -18. 5% for ESTA. At the gross margin level — before operating expenses — ALKS leads at 86. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is ESTA or DBVT or ALGN or ALKS or PRGO more undervalued right now?

On forward earnings alone, Perrigo Company plc (PRGO) trades at 5.

5x forward P/E versus 14. 9x for Align Technology, Inc. — 9. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PRGO: 208. 9% to $36. 20.

08

Which pays a better dividend — ESTA or DBVT or ALGN or ALKS or PRGO?

In this comparison, PRGO (9.

8% yield) pays a dividend. ESTA, DBVT, ALGN, ALKS do not pay a meaningful dividend and should not be held primarily for income.

09

Is ESTA or DBVT or ALGN or ALKS or PRGO better for a retirement portfolio?

For long-horizon retirement investors, Perrigo Company plc (PRGO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.

21), 9. 8% yield). Align Technology, Inc. (ALGN) carries a higher beta of 1. 65 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (PRGO: -77. 7%, ALGN: +123. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between ESTA and DBVT and ALGN and ALKS and PRGO?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: ESTA is a small-cap high-growth stock; DBVT is a mega-cap quality compounder stock; ALGN is a mid-cap quality compounder stock; ALKS is a small-cap quality compounder stock; PRGO is a small-cap income-oriented stock. PRGO pays a dividend while ESTA, DBVT, ALGN, ALKS do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

ESTA

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 22%
  • Gross Margin > 41%
Run This Screen
Stocks Like

DBVT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

ALGN

Steady Growth Compounder

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 6%
Run This Screen
Stocks Like

ALKS

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Net Margin > 5%
Run This Screen
Stocks Like

PRGO

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 20%
  • Dividend Yield > 3.9%
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.